Similar articles for PMID: 20696799

Year	Number of Results
1985	3
1986	6
1987	5
1988	5
1989	5
1990	7
1991	14
1992	6
1993	7
1994	3
1995	2
1996	2
1997	6
1998	1
1999	2
2003	3
2004	2
2005	1
2006	2
2007	3
2008	2
2009	3
2010	2
2011	1
2012	2
2013	3
2014	2
2015	1
2020	1
2024	0

1

Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.

Anglin RE, Rosebush PI, Mazurek MF. Anglin RE, et al. CMAJ. 2010 Dec 14;182(18):E834-8. doi: 10.1503/cmaj.091442. Epub 2010 Aug 9. CMAJ. 2010. PMID: 20696799 Free PMC article. Review. No abstract available.

2

Clinical features of neuroleptic malignant syndrome in basal ganglia disease. Spontaneous presentation in a patient with Hallervorden-Spatz disease in the absence of neuroleptic drugs.

Hayashi K, Chihara E, Sawa T, Tanaka Y. Hayashi K, et al. Anaesthesia. 1993 Jun;48(6):499-502. doi: 10.1111/j.1365-2044.1993.tb07070.x. Anaesthesia. 1993. PMID: 8322990 Free article.

3

Low serum iron and neuroleptic malignant syndrome.

Garcia FM, Duarte J, Perez A, Mataix AL, Coria F, Clavería LE. Garcia FM, et al. Ann Pharmacother. 1993 Jan;27(1):101-2. doi: 10.1177/106002809302700125. Ann Pharmacother. 1993. PMID: 8431609 No abstract available.

4

Iron, Parkinson's disease, and neuroleptic malignant syndrome.

Iwasaki Y, Kinoshita M, Ikeda K, Sugimoto H. Iwasaki Y, et al. Neurology. 1992 Sep;42(9):1845. doi: 10.1212/wnl.42.9.1845. Neurology. 1992. PMID: 1513485 No abstract available.

5

Hypophosphatemia and neuroleptic malignant syndrome.

Seitz DP. Seitz DP. J Clin Psychopharmacol. 2007 Jun;27(3):302-3. doi: 10.1097/01.jcp.0000270094.78027.bf. J Clin Psychopharmacol. 2007. PMID: 17502779 Review. No abstract available.

6

Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.

Trutia A, Bledowski J, Pandurangi A, Kahn DA. Trutia A, et al. J Psychiatr Pract. 2008 Nov;14(6):398-402. doi: 10.1097/01.pra.0000341895.66303.cc. J Psychiatr Pract. 2008. PMID: 19057242 No abstract available.

7

Neuroleptic malignant syndrome in an afebrile patient on second generation antipsychotics.

Chee A, Tay KH, Yap PP, Kwok V, Rawtaer I. Chee A, et al. Asian J Psychiatr. 2020 Apr;50:101938. doi: 10.1016/j.ajp.2020.101938. Epub 2020 Feb 11. Asian J Psychiatr. 2020. PMID: 32109803 No abstract available.

8

Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.

Yildiz A, Alkin T, Ozerdem A, Sagduyu K, Demopulos CM. Yildiz A, et al. Aust N Z J Psychiatry. 2003 Aug;37(4):493-4. doi: 10.1046/j.1440-1614.2003.01220.x. Aust N Z J Psychiatry. 2003. PMID: 12873338 No abstract available.

9

Neuroleptic malignant syndrome and its successful treatment with bromocriptine--a case report.

Javed A, Chaudhry HR. Javed A, et al. J Pak Med Assoc. 1991 Jan;41(1):19-20. J Pak Med Assoc. 1991. PMID: 1672170 No abstract available.

10

[Neuroleptic malignant syndrome in a patient treated with alimemazine].

Auffret M, Béné J, Lachatre M, Lambert M, Gautier S. Auffret M, et al. Therapie. 2013 May-Jun;68(3):173-4. doi: 10.2515/therapie/2013030. Epub 2013 Jul 26. Therapie. 2013. PMID: 23886464 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year